MedPath

Sodium Diet Effect on Aldosterone and Urinary RNA (SALTY)

Not Applicable
Completed
Conditions
Healthy
Interventions
Other: Low-sodium diet 10 mmol sodium/day
Other: High-sodium diet 300 mmol sodium/day
Registration Number
NCT04168073
Lead Sponsor
University of Michigan
Brief Summary

This cross-over clinical trial is being conducted to evaluate the difference in urinary messenger RNA (mRNA) biomarkers of mineralocorticoid receptor activation following a low-sodium diet, as compared to a high-sodium diet. The study team will collect urine and blood samples from each participant to study mineralocorticoid receptor-regulated mRNA biomarkers following the consumption of each diet.

The study team will instruct the participants to consume 8 days each of high- (300 mmol/day) and low- (10 mmol/day) sodium meals. The order in which the participants will eat the two study diets will be randomly determined. In between the high- and low-sodium diets, the participants will have a wash-out period of 6 days, during which they will be encouraged to consume their usual diet. Participants will be asked to provide the study team with 24-hour urine samples, random urine samples, and blood samples throughout their participation in this clinical trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Normotensive, as defined by:

    • Systolic blood pressure (SBP) < 140 mmHg and diastolic blood pressure (DBP) < 90 mmHg
    • Never prescribed an antihypertensive medication
  • Willingness to refrain from intense exercise (for example, swimming, biking, running)

Read More
Exclusion Criteria
  • Hypertension (history of blood pressure ≥ 140/90 mmHg)
  • History of hypertensive urgency, hypertensive crisis, or hospitalizations for hypertension
  • History of chronic kidney disease
  • History of heart failure
  • Current food allergy
  • Pregnancy
  • Known hyperaldosteronism
  • Current mineralocorticoid antagonist use
  • Current treatment for diabetes mellitus
  • Known adrenal insufficiency
  • Current glucocorticoid use
  • Electrolyte abnormality on baseline laboratory assessment
  • Current potassium supplementation
  • Urinary tract infection (UTI)
  • Significant renal insufficiency or any other condition thought by the Principal Investigator to place the participant at increased risk of injury during the clinical trial or compromise the scientific integrity of the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Low sodium dietLow-sodium diet 10 mmol sodium/day-
High sodium dietHigh-sodium diet 300 mmol sodium/day-
Primary Outcome Measures
NameTimeMethod
Urinary mineralocorticoid receptor-regulated mRNA biomarkerDay 29 (after second diet period)

Urinary mRNA biomarkers following consumption of a high-sodium and low-sodium diet will be measured using real-time quantitative polymerase chain reaction (RT-qPCR).

Urinary mineralocorticoid receptor-regulated messenger RNA (mRNA) biomarkerDay 15 (after first diet period)

Urinary mRNA biomarkers following consumption of a high-sodium and low-sodium diet will be measured using real-time quantitative polymerase chain reaction (RT-qPCR).

Secondary Outcome Measures
NameTimeMethod
Blood pressureDay 29 (after second diet period)

Systolic and diastolic blood pressure measurement following consumption of a high-sodium compared to a low-sodium diet

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath